Parameter
| Biomarker | RFC3 | Full name | Replication factor C subunit 3 Gene | Molecular Type | Nucleic acid (mRNA)/protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis, therapeutic targets | ||
| Disease | Non-Hodgkin Lymphoma (NHL) | Disease Subtypes | / | ||
| Organ | Lymphoid tissue | Test Sample / Technology Platform | Organization (GEO/TCGA analysis, immunohistochemistry) | ||
| Pathobiological Mechanisms | High expression is associated with adverse features and microenvironment deterioration, with pan-cancer prognostic value | ||||
| Clinical Availability Status | Research Validation Phase: Supported by multi-omics and pan-cancer analysis, requiring prospective validation and mechanistic studies. | ||||
| Notes and Dynamics | Conduct prospective cohort validation and conduct in-depth research on downstream pathway mechanisms. | ||||